CA2541848A1 - Intranasal delivery system - Google Patents

Intranasal delivery system Download PDF

Info

Publication number
CA2541848A1
CA2541848A1 CA002541848A CA2541848A CA2541848A1 CA 2541848 A1 CA2541848 A1 CA 2541848A1 CA 002541848 A CA002541848 A CA 002541848A CA 2541848 A CA2541848 A CA 2541848A CA 2541848 A1 CA2541848 A1 CA 2541848A1
Authority
CA
Canada
Prior art keywords
intranasal
dose
probe
delivery system
intranasal delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002541848A
Other languages
French (fr)
Other versions
CA2541848C (en
Inventor
Steven J. Penner
Randal W. Sebring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heska Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2640663A priority Critical patent/CA2640663C/en
Publication of CA2541848A1 publication Critical patent/CA2541848A1/en
Application granted granted Critical
Publication of CA2541848C publication Critical patent/CA2541848C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/0081—Locking means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073—Syringe, piston type

Abstract

A kit for intranasal delivery, comprises a dose, a diluent in which the dose may be combined, and an intranasal device. The intranasal device comprises an intranasal probe having a dose delivery aperture and a dose administrator having a first end and a second end, wherein the first end is responsive to the intranasal probe. An intranasal probe coupler is responsive to the intranasal probe and the first end of the dose administrator, wherein the intranasal probe coupler has at least one aperture which communicates between the dose administrator and the intranasal probe.
CA002541848A 1999-09-29 2000-09-29 Intranasal delivery system Expired - Lifetime CA2541848C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2640663A CA2640663C (en) 1999-09-29 2000-09-29 Intranasal delivery system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/408,584 US6398774B1 (en) 1999-09-29 1999-09-29 Intranasal delivery system
US09/408,584 1999-09-29
CA002386110A CA2386110C (en) 1999-09-29 2000-09-29 Intranasal delivery system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002386110A Division CA2386110C (en) 1999-09-29 2000-09-29 Intranasal delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2640663A Division CA2640663C (en) 1999-09-29 2000-09-29 Intranasal delivery system

Publications (2)

Publication Number Publication Date
CA2541848A1 true CA2541848A1 (en) 2001-04-05
CA2541848C CA2541848C (en) 2008-12-02

Family

ID=23616876

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002541848A Expired - Lifetime CA2541848C (en) 1999-09-29 2000-09-29 Intranasal delivery system
CA002386110A Expired - Lifetime CA2386110C (en) 1999-09-29 2000-09-29 Intranasal delivery system
CA2640663A Expired - Lifetime CA2640663C (en) 1999-09-29 2000-09-29 Intranasal delivery system

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002386110A Expired - Lifetime CA2386110C (en) 1999-09-29 2000-09-29 Intranasal delivery system
CA2640663A Expired - Lifetime CA2640663C (en) 1999-09-29 2000-09-29 Intranasal delivery system

Country Status (5)

Country Link
US (2) US6398774B1 (en)
EP (1) EP1225941A4 (en)
AU (4) AU774757B2 (en)
CA (3) CA2541848C (en)
WO (1) WO2001023018A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6398774B1 (en) * 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
CA2523676A1 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8721699B2 (en) 2005-05-13 2014-05-13 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US9358150B2 (en) 2005-05-13 2016-06-07 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US7824436B2 (en) * 2005-05-13 2010-11-02 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
NO346351B1 (en) 2005-10-19 2022-06-20 Intervet Int Bv Isolated Canine Influenza Avirus, Polynucleotide Expression Construct, Isolated Antibody, Isolated Cell, Reassortant Virus and Recombinant Virus Vector, and Composition and Canine Influenza Vaccine
US20080033038A1 (en) * 2006-07-07 2008-02-07 Shytle R D Compositions of polyphenols and methods of use
US7749191B2 (en) * 2008-03-20 2010-07-06 Beutlich Lp, Pharmaceuticals Device and method for drug delivery
US8015873B2 (en) * 2008-04-25 2011-09-13 Hall David L Detector housing
WO2010054249A1 (en) * 2008-11-07 2010-05-14 Benechill, Inc. Methods of nasopharyngeal cooling for augmenting coronary perfusion pressure
CA2764759A1 (en) 2009-06-09 2010-12-16 Defyrus, Inc. Administration of interferon for prophylaxis against or treatment of pathogenic infection
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
EP2442861B1 (en) 2009-06-19 2019-01-02 BrainCool AB Devices for cooling the nasal cavity
CN114010776A (en) 2010-06-09 2022-02-08 疫苗技术股份有限公司 Therapeutic immunization of HIV-infected persons for enhancing antiretroviral therapy
JP6152378B2 (en) 2011-05-11 2017-06-21 チルドレンズ メディカル センター コーポレーション Multiple antigen presenting immunogenic compositions and methods and uses thereof
JP6494527B2 (en) 2013-02-07 2019-04-03 ザ チルドレンズ メディカル センター コーポレーション Protein antigens that provide protection from pneumococcal colonization and / or disease
BR112019000938B1 (en) * 2016-07-20 2023-05-02 Bovicor Pharmatech Inc. DEVICE FOR INTRANASAL DELIVERY FOR AN ANIMAL

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950512A (en) 1972-07-25 1976-04-13 Pitman-Moore, Inc. Animal vaccines
US4009258A (en) 1972-09-25 1977-02-22 The Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US3927208A (en) 1973-05-14 1975-12-16 Rit Rech Ind Therapeut Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
US3953592A (en) 1973-09-27 1976-04-27 Recherche Et Industrie Therapeutiques (R.I.T.) Live influenza virus vaccines and preparation thereof
US4132775A (en) 1973-12-03 1979-01-02 Richardson-Merrell Inc. Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
FR2262962B1 (en) 1974-03-05 1977-11-04 Science Union & Cie
US4195076A (en) 1974-03-05 1980-03-25 Science Union Et Cie, Societe Francaise De Recherche Medicale Process for the preparation of hemagglutinin from viral sources and methods of utilizing same
US4029763A (en) 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same
US3962422A (en) 1975-02-18 1976-06-08 Syntex (U.S.A.) Inc. Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus
US4053583A (en) 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
US4110427A (en) 1976-04-14 1978-08-29 The Risdon Manufacturing Company Powdered solid aerosol composition and method of manufacture
US4110433A (en) 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
US4512972A (en) 1980-06-30 1985-04-23 Kureha Chemical Industry Co., Ltd. Nasal preparation and processes for their production
US4554159A (en) 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US4683137A (en) 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) 1983-01-08 1983-02-09 Wellcome Found Equine influenza
JPS59163313A (en) 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
US4554158A (en) 1983-04-07 1985-11-19 Simonsen Laboratories, Inc. Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4767416A (en) * 1986-12-01 1988-08-30 Johnson & Johnson Patient Care, Inc. Spray nozzle for syringe
NZ224422A (en) 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US4800078A (en) 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
US5250298A (en) 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US4923448A (en) * 1988-12-06 1990-05-08 Mark Anderson Syringe with spray nozzle tip
US5158761A (en) 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5215739A (en) 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5062423A (en) * 1990-02-27 1991-11-05 Minnesota Mining And Manufacturing Company Equine aerosol drug delivery method and apparatus
DE4016126A1 (en) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa DEVICE FOR TRANSNASAL OR ORAL ADMINISTRATION OF MEDICATIONS OR THE LIKE
US5053022A (en) * 1990-06-28 1991-10-01 Mobay Corporation Applicator for intranasal administration of vaccines to horses
IT1244803B (en) * 1990-11-21 1994-09-05 Promo Pack S A SINGLE-DOSE DISPENSER-SPRAYER FOR ENDONASAL ADMINISTRATION OF LIQUID MEDICATIONS.
US5331954A (en) * 1990-12-21 1994-07-26 Novo Nordisk A/S Device for nasal delivery of liquid medications
US5601077A (en) 1991-08-07 1997-02-11 Becton, Dickinson And Company Nasal syringe sprayer with removable dose limiting structure
US5429599A (en) * 1994-05-02 1995-07-04 Heinke; Richard M. Method and means for delivering a pharmaceutical into the nostril of an animal
DE19518810A1 (en) * 1995-05-26 1996-11-28 Bayer Ag Nasal applicator
US5683137A (en) 1996-05-15 1997-11-04 Bright Ideas Group, Inc. Time-out chair/seat
US5746762A (en) 1996-06-24 1998-05-05 Bass; Lawrence S. Device and method for surgical flap dissection
US6398774B1 (en) * 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US6382204B1 (en) * 1999-10-14 2002-05-07 Becton Dickinson And Company Drug delivery system including holder and drug container

Also Published As

Publication number Publication date
AU2004218666B2 (en) 2006-08-31
AU774757B2 (en) 2004-07-08
EP1225941A2 (en) 2002-07-31
AU7737600A (en) 2001-04-30
EP1225941A4 (en) 2007-07-11
AU2006236004A1 (en) 2006-12-07
AU2008202537A1 (en) 2008-06-26
AU2004218666A1 (en) 2004-11-04
CA2541848C (en) 2008-12-02
CA2640663C (en) 2011-09-13
WO2001023018A2 (en) 2001-04-05
US6398774B1 (en) 2002-06-04
WO2001023018A3 (en) 2001-12-06
CA2640663A1 (en) 2001-04-05
CA2386110C (en) 2006-05-30
US7204822B1 (en) 2007-04-17
CA2386110A1 (en) 2001-04-05
AU2006236004B2 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
CA2541848A1 (en) Intranasal delivery system
USD451584S1 (en) Universal hose connector
CA2377454A1 (en) Broadband antenna structure
AU9594298A (en) A lysis chamber for use in an assay device
WO2001085550A3 (en) Specimen plate lid and method of using
AU2002340071A1 (en) Fuel injecton nozzle adapter
AU2184401A (en) Low-permeability connecting device
WO2002051470A3 (en) Injection systems
AU2001268459A1 (en) Secure test and test result delivery system
AU2001296908A1 (en) Proton pump inhibitor formulation
AU2912797A (en) Device for genuine stress incontinence in the female
CA2436026A1 (en) Barrel assembly for an injection molding machine
AU2000245328A1 (en) Coupling device
AU2002221607A1 (en) Pmd -emulation, measurement and compensating device
CA2302224A1 (en) Fibrinogen-based tissue adhesive
CA2179132A1 (en) Fitting for an appliance such as a sink
AU2001284031A1 (en) Incubation device
AU1200301A (en) Self terminating coaxial coupler
WO2002009632A3 (en) Medical device support assembly
WO1999051350A3 (en) Device for receiving and discharging a given amount of liquid
AU4610501A (en) Coupling device
AU2204500A (en) Axial-on threaded coupling device
AU5127700A (en) An intravaginal catamenial device
AU2001291012A1 (en) Flat plate flaking device
AU3082900A (en) Coupling device

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200929